Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma

被引:4
作者
Huang, Quan [1 ]
Li, Lin [1 ]
Lin, Zaijun [1 ]
Xu, Wei [1 ]
Han, Shuai [1 ]
Zhao, Chenglong [1 ]
Li, Lei [1 ]
Cao, Wenjiao [2 ]
Yang, Xinghai [1 ]
Wei, Haifeng [1 ]
Xiao, Jianru [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, Shanghai, Peoples R China
[2] China Welf Inst IPMCH, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2016年 / 22卷
关键词
Apoptosis; Cell Proliferation; Lung Diseases; PRAME EXPRESSION; CELL-PROLIFERATION; CANCER; OSTEOSARCOMA; APOPTOSIS; RECEPTOR; HYPOXIA; ARREST; GENE; P53;
D O I
10.12659/MSM.895642
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Preferentially expressed antigen of melanoma (PRAME) is known as a tumor-associated antigen that is altered in a variety of malignancies, including lung cancer. However, the role of PRAME in lung cancer remains unclear. Material/Methods: We analyzed the expression of PRAME in human lung adenocarcinomas and studied the function of PRAME using small interfering RNA (siRNA)-induced gene knockdown in lung cancer cell lines PC9 and A549. Results: We found that PRAME expression is down-regulated in lung adenocarcinomas. Knockdown of PRAME promoted proliferation and suppressed apoptosis of PC9 and A549 cells. Conclusions: In line with its roles in controlling cell growth, RPAME regulates multiple critical cell-growth related genes, including IGF1R oncogene. IGF1R up-regulation contributes to increase of cell growth upon the knockdown of PRAME. Taken together, our results suggest that PRAME has inhibitory roles in lung cancer.
引用
收藏
页码:1837 / 1842
页数:6
相关论文
共 22 条
[1]   Role of BNIP3 in proliferation and hypoxia-induced autophagy: implications for personalized cancer therapies [J].
Azad, Meghan B. ;
Gibson, Spencer B. .
TOWARD PERSONALIZED MEDICINE FOR CANCER, 2010, 1210 :8-16
[2]   Identification of genes associated with non-small-cell lung cancer promotion and progression [J].
Bankovic, Jasna ;
Stojsic, Jelena ;
Jovanovic, Dragana ;
Andjelkovic, Tijana ;
Milinkovic, Vedrana ;
Ruzdijic, Sabera ;
Tanic, Nikola .
LUNG CANCER, 2010, 67 (02) :151-159
[3]   Control of proliferation by Bcl-2 family members [J].
Bonnefoy-Berard, N ;
Aouacheria, A ;
Verschelde, C ;
Quemeneur, L ;
Marcais, A ;
Marvel, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1644 (2-3) :159-168
[4]   miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma [J].
Chen, Lei ;
Wang, Qing ;
Wang, Guo-dong ;
Wang, Hua-song ;
Huang, Yong ;
Liu, Xi-ming ;
Cai, Xian-hua .
FEBS LETTERS, 2013, 587 (09) :1366-1372
[5]   Calcium deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates abnormal epithelial cell proliferation [J].
Dai, W. ;
Bai, Y. ;
Hebda, L. ;
Zhong, X. ;
Liu, J. ;
Kao, J. ;
Duan, C. .
CELL DEATH AND DIFFERENTIATION, 2014, 21 (04) :568-581
[6]  
De Carvalho DD, 2013, CURR MOL MED, V13, P296
[7]   PRAME expression and clinical outcome of breast cancer [J].
Epping, M. T. ;
Hart, A. A. M. ;
Glas, A. M. ;
Krijgsman, O. ;
Bernards, R. .
BRITISH JOURNAL OF CANCER, 2008, 99 (03) :398-403
[8]   The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling [J].
Epping, MT ;
Wang, LM ;
Edel, MJ ;
Carlée, L ;
Hernandez, M ;
Bernards, R .
CELL, 2005, 122 (06) :835-847
[9]   Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth [J].
Fei, PW ;
Wang, WG ;
Kim, SH ;
Wang, SL ;
Burns, TF ;
Sax, JK ;
Buzzai, M ;
Dicker, DT ;
McKenna, WG ;
Bernhard, EJ ;
El-Deiry, WS .
CANCER CELL, 2004, 6 (06) :597-609
[10]   Lost in transcription: p21 repression, mechanisms, and consequences [J].
Gartel, AL ;
Radhakrishnan, SK .
CANCER RESEARCH, 2005, 65 (10) :3980-3985